(Q33717191)

28 July 2017

1 reference

title

Interleukin-10: a cytokine used by tumors to escape immunosurveillance (English)

1 reference

28 July 2017

Salazar-Onfray F

1

1 reference

28 July 2017

1 July 1999

1 reference

28 July 2017

1 reference

28 July 2017

16

1 reference

28 July 2017

2

1 reference

28 July 2017

86-94

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02785841

28 July 2017

0 references

cites work

Antigen recognition by class I-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FBF02785841

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02785841

Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02785841

Expression of interleukin 10 in human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02785841

Interferons increase transcription of a major histocompatibility class I gene via a 5' interferon consensus sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02785841

Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells

21 January 2018

1 reference

12 December 2020

Generation, intracellular transport and loading of peptides associated with MHC class I molecules

1 reference

12 December 2020

A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability

1 reference

12 December 2020

Expression of transforming growth factor-beta 1 in prostate cancer.

1 reference

12 December 2020

Altered immune responses in interleukin 10 transgenic mice

1 reference

12 December 2020

IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression

1 reference

12 December 2020

An active T-cell-independent mechanism enhances MHC class I transcription and expression on a mouse T-cell lymphoma in vivo

1 reference

12 December 2020

Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration.

1 reference

12 December 2020

Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2

1 reference

12 December 2020

Differential growth factor production, secretion, and response by high and low metastatic variants of B16BL6 melanoma

1 reference

12 December 2020

Molecular analysis of H-2-deficient lymphoma lines. Distinct defects in biosynthesis and association of MHC class I heavy chains and beta 2-microglobulin observed in cells with increased sensitivity to NK cell lysis

1 reference

12 December 2020

Ham-2 corrects the class I antigen-processing defect in RMA-S cells

1 reference

12 December 2020

Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.

1 reference

12 December 2020

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1 reference

12 December 2020

Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism

1 reference

12 December 2020

A functional dichotomy in CD4+ T lymphocytes

1 reference

12 December 2020

Prostaglandin E2 down-regulates the expression of HLA-DR antigen in human colon adenocarcinoma cell lines

1 reference

12 December 2020

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

12 December 2020

Cytotoxic T cells recognize fragments of the influenza nucleoprotein

1 reference

12 December 2020

IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages

1 reference

12 December 2020

Empty MHC class I molecules come out in the cold

1 reference

12 December 2020

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression

1 reference

12 December 2020

High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer

1 reference

12 December 2020

Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma

1 reference

12 December 2020

Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101

1 reference

12 December 2020

High frequency of altered HLA class I phenotypes in invasive breast carcinomas

1 reference

12 December 2020

A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer

1 reference

12 December 2020

Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer

1 reference

12 December 2020

A viral inhibitor of peptide transporters for antigen presentation

1 reference

12 December 2020

IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo

1 reference

12 December 2020

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

12 December 2020

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

1 reference

12 December 2020

MHC antigens on human tumors

1 reference

12 December 2020

Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition

1 reference

12 December 2020

Interferon-gamma and interleukin-10 have cross-regulatory roles in modulating the class I and class II MHC-mediated presentation of epitopes of Listeria monocytogenes by infected macrophages

1 reference

12 December 2020

Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis

1 reference

12 December 2020

IL-10, a novel growth cofactor for mature and immature T cells

1 reference

12 December 2020

High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.

1 reference

12 December 2020

Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival

1 reference

12 December 2020

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism

1 reference

12 December 2020

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

1 reference

12 December 2020

Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers

1 reference

12 December 2020

Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer.

1 reference

12 December 2020

Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies

1 reference

12 December 2020

Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions

1 reference

12 December 2020

Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells.

1 reference

12 December 2020

Herpes simplex virus turns off the TAP to evade host immunity

1 reference

12 December 2020

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

12 December 2020

IL-10 inhibits cytokine production by activated macrophages

1 reference

12 December 2020

Natural history of HLA expression during tumour development.

1 reference

12 December 2020

„Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell

1 reference

12 December 2020

Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors

1 reference

12 December 2020

Human B cell interleukin 10.

1 reference

12 December 2020

Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules

1 reference

12 December 2020

IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells

1 reference

12 December 2020

Modulation of sensitivity to natural killer cell lysis after in vitro explantation of a mouse lymphoma

1 reference

12 December 2020

Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens

1 reference

12 December 2020

Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma

1 reference

12 December 2020

Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis

1 reference

12 December 2020

Mechanisms of escape from CD8+ T-cell clones specific for the HER-2/neu proto-oncogene expressed in ovarian carcinomas: related and unrelated to decreased MHC class 1 expression

1 reference

12 December 2020

Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter

1 reference

12 December 2020

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

1 reference

12 December 2020

Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10.

1 reference

12 December 2020

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

1 reference

12 December 2020

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

12 December 2020

IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.

1 reference

12 December 2020

Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.

1 reference

12 December 2020

In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.

1 reference

12 December 2020

Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.

1 reference

12 December 2020

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

1 reference

12 December 2020

Human interleukin-10 can directly inhibit T-cell growth

1 reference

12 December 2020

Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression.

1 reference

12 December 2020

LMP-associated proteolytic activities and TAP-dependent peptide transport for class 1 MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12.

1 reference

12 December 2020

Human non-small cell lung cancer cells express a type 2 cytokine pattern.

1 reference

12 December 2020

Progressive Loss of H-2 Antigens With Concomitant Increase of Cell-Surface Antigen(s) Determined by Moloney Leukemia Virus in Cultured Murine Lymphomas23

1 reference

12 December 2020

Proteolysis, proteasomes and antigen presentation

1 reference

12 December 2020

IL-10: a novel cytotoxic T cell differentiation factor

1 reference

12 December 2020

Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy

1 reference

12 December 2020

1 reference

12 December 2020

Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2

1 reference

12 December 2020

Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression

1 reference

12 December 2020

Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1.

1 reference

12 December 2020

T Helper 1 Cytokine mRNA Is Increased in Spontaneously Regressing Primary Melanomas

1 reference

12 December 2020

Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

1 reference

12 December 2020

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

1 reference

12 December 2020

Lipid-bound sialic acid, prostaglandin E and histamine in head and neck cancer

1 reference

12 December 2020

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

1 reference

12 December 2020

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

1 reference

12 December 2020

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02785841

1 reference

PubMed ID

10456656

Dimensions Publication ID

28 July 2017

0 references

1 reference

PubMed ID

10456656